End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.75 CNY | +0.45% | +4.49% | -23.03% |
Apr. 10 | Tecon Biology's Pig Sales Revenue Climbs 12% in March | MT |
Apr. 08 | Tiankang Biotechnology's Chairman Retires | MT |
Sales 2023 * | 18.06B 2.49B | Sales 2024 * | 21.11B 2.92B | Capitalization | 9.22B 1.27B |
---|---|---|---|---|---|
Net income 2023 * | -735M -102M | Net income 2024 * | 765M 106M | EV / Sales 2023 * | 0.76 x |
Net Debt 2023 * | 4.43B 612M | Net Debt 2024 * | 4.36B 603M | EV / Sales 2024 * | 0.64 x |
P/E ratio 2023 * |
-12.5
x | P/E ratio 2024 * |
12
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
0.98% | Free-Float | 65.06% |
1 day | +0.45% | ||
1 week | +3.69% | ||
Current month | -11.76% | ||
1 month | -13.13% | ||
3 months | -11.07% | ||
6 months | +2.12% | ||
Current year | -23.03% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Cheng
CEO | Chief Executive Officer | 59 | 03-12-19 |
Li Xin Geng
DFI | Director of Finance/CFO | 57 | 10-01-20 |
Yun Jiang Guo
BRD | Director/Board Member | 54 | 07-03-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yan Yang
CHM | Chairman | 62 | 03-12-19 |
Hui Cheng
CEO | Chief Executive Officer | 59 | 03-12-19 |
Li Xin Geng
DFI | Director of Finance/CFO | 57 | 10-01-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 6.75 | +0.45% | 8,539,733 |
24-04-24 | 6.72 | -1.61% | 14,872,790 |
24-04-23 | 6.83 | +0.15% | 19,270,270 |
24-04-22 | 6.82 | +6.90% | 33,675,940 |
24-04-19 | 6.38 | -1.24% | 13,231,900 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.03% | 1.27B | |
-2.25% | 95.92B | |
+3.76% | 46.89B | |
+1.06% | 40.99B | |
+9.58% | 40.43B | |
+0.38% | 38.42B | |
-15.54% | 30.89B | |
-3.64% | 28.96B | |
+13.48% | 25.11B | |
-10.87% | 22.3B |
- Stock Market
- Equities
- 002100 Stock